Dose-Finding
Showing 26 - 50 of >10,000
Hyperthermic Intraperitoneal Chemo Trial in Guangzhou (Docetaxel)
Recruiting
- Hyperthermic Intraperitoneal Chemotherapy
-
Guangzhou, Other (Non U.s.), ChinaSun Yat-sen Memorial Hospital
Jun 6, 2022
Healthy Trial in Zürich (Dimethyltryptamin (DMT) & Harmine)
Not yet recruiting
- Healthy
- Dimethyltryptamin (DMT) & Harmine
-
Zürich, ZH, SwitzerlandUniversity Hospital of Psychiatry Zurich
Apr 13, 2023
Hemophilia B Without Inhibitor Trial (Low dose KL001, Middle dose KL001, High dose KL001)
Not yet recruiting
- Hemophilia B Without Inhibitor
- Low dose KL001
- +2 more
- (no location specified)
Nov 5, 2023
Contraception Trial in Aurora (Drospirenone-only pill)
Not yet recruiting
- Contraception
- Drospirenone-only pill
-
Aurora, ColoradoUniversity of Colorado Denver
Dec 21, 2022
Huntington Disease Trial in Paris (BV-101 Gene Therapy)
Not yet recruiting
- Huntington Disease
- BV-101 Gene Therapy
-
Paris, Ile-de-France, FranceInstitut du Cerveau (ICM), Hôpital La Pitié Salpêtrière APHP
Sep 13, 2022
Laceration Repair Trial in London (Dexmedetomidine)
Completed
- Laceration Repair
-
London, Ontario, CanadaLondon Health Sciences Centre
Apr 5, 2022
Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME) Trial in United States (EYE103)
Recruiting
- Neovascular Age-related Macular Degeneration (NVAMD)
- Diabetic Macular Edema (DME)
-
Phoenix, Arizona
- +4 more
Jun 14, 2023
Malaria Trial (Meplazumab for Injection)
Not yet recruiting
- Malaria
- Meplazumab for Injection
- (no location specified)
Sep 13, 2023
Proteus Syndrome Trial run by the NHGRI (MK-7075 (miransertib))
Completed
- Proteus Syndrome
- MK-7075 (miransertib)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2022
Orthopedic Surgery Trial in Seoul (Remimazolam bolus does administration)
Recruiting
- Orthopedic Surgery
- Remimazolam bolus does administration
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Mar 16, 2022
Atherosclerotic Cardiovascular Disease, End Stage Kidney Disease Trial (CSL300, Placebo)
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- End Stage Kidney Disease
- CSL300
- Placebo
- (no location specified)
Aug 1, 2022
Cystic Fibrosis Trial in Cologne (OligoG Dry powder for inhalation)
Withdrawn
- Cystic Fibrosis
- OligoG Dry powder for inhalation
-
Cologne, GermanyCF Zentrum Köln, Universitätskrankenhaus Köln
Jun 27, 2022
COVID-19 Trial in Bloemfontein, Pretoria, Soweto (Candidate vaccine, SCB-2020S, Candidate vaccine, SCB-2019, Squalene based
Active, not recruiting
- COVID-19
- Candidate vaccine, SCB-2020S
- +3 more
-
Bloemfontein, South Africa
- +2 more
Oct 18, 2022
Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)
Recruiting
- Glioblastoma, IDH-wildtype
- MGMT-Methylated Glioblastoma
-
Padova, ItalyIstituto Oncologico Veneto IRCCS
Oct 18, 2023
Cancer Trial (Antibody-Drug Conjugate)
Not yet recruiting
- Cancer
- Antibody-Drug Conjugate
- (no location specified)
Aug 23, 2023
Birth Asphyxia Trial in Kawempe (Sildenafil)
Recruiting
- Birth Asphyxia
-
Kawempe, UgandaKawempe National Referral Hospital
Aug 12, 2022
Medication Adherence Trial in Manhasset (5 Behavioral Change Techniques)
Recruiting
- Medication Adherence
- 5 Behavioral Change Techniques
-
Manhasset, New YorkNorthwell Health
Jul 12, 2023
Post-Bariatric Hypoglycemia Trial (Pasireotide Diaspartate)
Not yet recruiting
- Post-Bariatric Hypoglycemia
- Pasireotide Diaspartate
- (no location specified)
Jul 7, 2023
Cytomegalovirus Infection Trial in United States (mRNA-1647, Placebo)
Completed
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Sacramento, California
- +8 more
Jan 11, 2023
Soft Tissue Sarcoma Trial in Santa Monica (L19TNF, DOXORUBICIN)
Active, not recruiting
- Soft Tissue Sarcoma
-
Santa Monica, CaliforniaSarcoma Oncology Research Center (SORC) Cancer Center of Souther
Apr 19, 2022
Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)
Not yet recruiting
- Tuberculosis
- BNT164a1
- +2 more
- (no location specified)
Jan 18, 2023